Daiichi Sankyo Company, Limited (TYO:4568)
2,849.00
-18.00 (-0.63%)
At close: Mar 9, 2026
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 19,765 employees as of March 31, 2025. The number of employees increased by 1,039 or 5.55% compared to the previous year.
Employees
19,765
Change (1Y)
1,039
Growth (1Y)
5.55%
Revenue / Employee
103.83M JPY
Profits / Employee
15.41M JPY
Market Cap
5,263.97B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Otsuka Holdings | 37,758 |
| Astellas Pharma | 13,643 |
| Chugai Pharmaceutical | 7,872 |
| Kyowa Kirin | 5,669 |
| Ono Pharmaceutical | 4,287 |
| Santen Pharmaceutical | 3,849 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Daiichi Sankyo Company News
- 4 days ago - GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe. - Business Wire
- 14 days ago - SylamoreBio Announces Research Collaboration With Daiichi Sankyo to Advance SyLEC™ Delivery Technology - Business Wire
- 17 days ago - Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D - Business Wire
- 20 days ago - BostonGene Announces Strategic Collaboration with Daiichi Sankyo to Accelerate Drug Development Through AI-Driven Multimodal Analytics - Business Wire
- 4 weeks ago - DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo - Business Wire
- 6 weeks ago - Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe - Business Wire
- 6 weeks ago - Daiichi Sankyo Unveils New Toronto Headquarters to Accelerate Investment and Innovation in Oncology - PRNewsWire
- 2 months ago - Organon Enters into a Commercialization Agreement for Daiichi Sankyo's Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway - Business Wire